Navigation Links
Reportlinker Adds Global Sleeping Pills Industry
Date:10/4/2010

NEW YORK, Oct. 4 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Sleeping Pills Industry

http://www.reportlinker.com/p0305164/Global-Sleeping-Pills-Industry.html

This report analyzes the Global market for Sleeping Pills in US$ Million. Annual estimates and forecasts are provided for the period of 2007 through 2015. Also, a six-year historic analysis is provided for this market. The report profiles 34 companies including many key and niche players such as Actelion Pharmaceuticals Ltd., Abbott India Limited, Apotex Inc., Aurobindo Pharma Limited, Caraco Pharmaceutical Laboratories, Ltd., Dr. Reddy's Laboratories Limited, H. Lundbeck A/S, King Pharmaceuticals Inc., Neurocrine Biosciences, Ranbaxy Laboratories Limited, Roxane Laboratories, Inc., Sepracor Inc., Sanofi-aventis, Somaxon Pharmaceuticals Inc., Synthon BV, Takeda Pharmaceutical Company Limited, and Transcept Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

SLEEPING PILLS MCP-6368

A GLOBAL MARKET REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Quantitative Techniques & Analytics I-3

Product Definition and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

Safety Concerns and Generics Characterize the Market II-1

"Perfect" Treatment Option Continues to Evade Insomnia

Therapeutics Arena II-1

A Market Characterized by Weak Pipeline II-2

Market Outlook II-2

Sleep Disorders - Not Confined to Elderly Alone II-2

US Leads the Global Market for Sleeping Pills II-2

Table 1: US Prevalence of Chronic Insomnia by Type: 2008

(includes corresponding Graph/Chart) II-3

Studies Cast Doubt On the Efficacy of Sleeping Pills II-3

2. SLEEPING PILLS MARKET SEGMENTATION II-4

Market Categorization II-4

Table 2: Select Benzodiazepines and Non-Benzodiazepines

Worldwide II-4

Benzodiazepines Loose Sheen Due to Associated Side Effects II-5

'Z' Drugs Outshine Benzodiazepines with Lesser Adverse Effects II-5

Table 3: Sales of Select Leading Sleeping Pills Worldwide II-5

Melatonin Receptor Agonist Hypnotic II-6

Rozerem - The Only Drug without the Risk of Dependency II-6

3. MAJOR SLEEPING PILLS WORLDWIDE II-7

Zolpidem (Sanofi-Aventis/Various) II-7

Ambien CR (Sanofi-Aventis) II-7

Lunesta (Sepracor) II-7

Intermezzo (Transcept) II-8

Sonata (King Pharmaceuticals) II-8

Imovane (Sanofi-Aventis) II-8

4. SLEEP DISORDER PIPELINE ANALYSIS II-10

5. PRODUCT OVERVIEW II-11

Insomnia - A Review II-11

Impact on Day-to-day Life II-11

Insomnia: An Under-Diagnosed Disease II-11

Middle-Of-The-Night Insomnia II-12

What are Sleeping Pills? II-12

When it Should be Taken? II-12

Side Effects - A Key Concern II-12

Natural Treatment of Insomnia II-13

Eye Cells - A New Potential Target for Sleeping Pills II-13

6. REGIONAL MARKET PERSPECTIVE II-14

6A. THE UNITED STATES II-14

Economic Woes Drive Usage of Sleeping Pills II-14

Table 4: Sleeping Pills Prescription Volume in the US:

2006-2008 (includes corresponding Graph/Chart) II-14

Table 5: Sleeping Pills Prescription Volume in the US by

Drug: 2006-2008 (In Million) (includes corresponding

Graph/Chart) II-15

Dangerous Signs for Americans II-15

OTC Sleeping Aids Market Review II-15

Table 6: Leading OTC Sleeping Aid Tablets in the US (2008):

Percentage Breakdown of Value Sales for Simply Sleep, Unisom

SleepGels, Unisom SleepTabs, Sleep MD, Sominex, Midnite,

Breathe Right, Sleepinal, Private Label Brands and Others

(includes corresponding Graph/Chart) II-16

Table 7: Leading OTC Sleeping Aid Tablets in the US (2008):

Percentage Breakdown of Volume Sales for Simply Sleep,

Unisom SleepGels, Sominex, Unisom SleepTabs, Sleep MD,

Midnite, Sleepinal, Breathe Right, Private Labels and Others

(includes corresponding Graph/Chart) II-16

Table 8: Leading OTC Sleeping Aid Liquid Drugs in the US

Drug Stores (2007): Percentage Breakdown of Value Sales for

Breathe Right, Snorestop, Bach Rescue Sleep, Nutramist Sleep

Now, Nutranetics Liquid Sleep and Others (includes

corresponding Graph/Chart) II-17

Table 9: Leading OTC Sleeping Pills in US Drug Stores (2007):

Percentage Breakdown of Value Sales for Simply Sleep, Unisom

Sleepgels, Sleep MD, Unisom, Sominex and Others (includes

corresponding Graph/Chart) II-17

Table 10: Leading OTC Sleeping Pills in US Drug Stores

(2007): Percentage Breakdown of Volume Sales for Simply

Sleep, Unisom Sleepgels, Sominex, Unisom, Sleep MD and

Others (includes corresponding Graph/Chart) II-17

6B. EUROPE II-18

Europe: A Major Market for Sleeping Pills II-18

Table 11: European Prevalence of Chronic Insomnia by Type:

2008 (includes corresponding Graph/Chart) II-18

Table 12: Sleeping Disorders in Europe (2008): Prevalence

Rate by Age Group for Select European Countries - France,

Germany, Italy, UK (includes corresponding Graph/Chart) II-19

Table 13: Sleeping Disorders in Europe (2008): Prevalence

Rate by Gender for Select European Countries - France,

Germany, Italy, UK (includes corresponding Graph/Chart) II-19

6C. JAPAN II-20

Illegal Sales of Sleeping Pills Rampant in Japan II-20

6D. TAIWAN II-20

Sleeping Pills Sales Continue to Soar II-20

7. RECENT INDUSTRY ACTIVITY II-21

Somaxon Pharma Receives US FDA Approval for Silenor II-21

Transcept Pharmaceuticals Merges with Novacea II-21

Sepracor Files Lawsuits Against ANDA Filers for Eszopiclone II-21

Dainippon Sumitomo Takes Over Sepracor II-22

FDA Puts Two Pediatric Studies of Lunesta on Hold II-22

Transcept Pharmaceuticals Signs Deal with Purdue

Pharmaceutical Products II-22

Sepracor Receives Approval for Lunesta Oral Tablet II-23

FDA Approves Mylan's ANDA for Zaleplon Capsules II-23

GlaxoSmithKline Signs Agreement with Actelion II-23

Lundbeck Launches Circadin® in Germany for Insomnia II-23

Lundbeck Launches Circadin in the UK II-24

Transcept Completes Phase III Study of Intermezzo, Files NDA II-24

Evotec Scouts for Partners to Develop EVT 201 II-24

Aurobindo Pharma Receives FDA Approval for Zaleplon II-24

Australia's TGA Orders Boxed Warnings for Stilnox II-24

Sepracor Obtains Positive Opinion for Approval of Lunivia from

CHMP II-25

Caraco Obtains FDA Approval for Generic Zolpidem II-25

FDA Approves ANDA of Dr. Reddy's Laboratories for Zolpidem

Tartrate II-25

Ranbaxy Obtains FDA Clearance to Market Generic Ambien® II-25

Neurocrine Obtains Second Approvable Letter from FDA for

Indiplon Capsules II-26

Roxane Launches Zolpidem Tartrate Tablets II-26

8. FOCUS ON SELECT PLAYERS II-27

Actelion Pharmaceuticals Ltd. (Switzerland) II-27

Abbott India Limited (India) II-27

Apotex Inc. (Canada) II-27

Aurobindo Pharma Limited (India) II-28

Caraco Pharmaceutical Laboratories, Ltd. (US) II-28

Dr. Reddy's Laboratories Limited (India) II-28

H. Lundbeck A/S (Denmark) II-28

King Pharmaceuticals, Inc. (US) II-28

Neurocrine Biosciences (US) II-29

Ranbaxy Laboratories Limited (India) II-29

Roxane Laboratories, Inc. (US) II-30

Sepracor, Inc. (USA) II-30

Sanofi-aventis (France) II-30

Somaxon Pharmaceuticals, Inc. (US) II-31

Synthon BV (The Netherlands) II-31

Takeda Pharmaceutical Company Limited (Japan) II-31

Transcept Pharmaceuticals, Inc. (US) II-32

9. GLOBAL MARKET PERSPECTIVE II-33

Table 14: World Recent Past, Current and Future Analysis for

Sleeping Pills by Geographic Region - US, and Rest of World

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) II-33

Table 15: World Historic Review for Sleeping Pills by

Geographic Region - US, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) II-34

Table 16: World 13-Year Perspective for Sleeping Pills by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, and Rest of World Markets for Years 2003, 2009 and 2015 II-34

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 34 (including Divisions/Subsidiaries - 39)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 22

Canada 1

Japan 3

Europe 9

France 1

Germany 2

The United Kingdom 1

Rest of Europe 5

Asia-Pacific (Excluding Japan) 4

------------------------------------------

To order this report:Drug and Medication Industry: Global Sleeping Pills Industry

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!CONTACT:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Global Immunoassay Systems Industry
2. Reportlinker Adds Global Medical Plastics Industry
3. Reportlinker Adds Global Optoelectronics Industry
4. Reportlinker Adds Global Gas Chromatography Systems Industry
5. Reportlinker Adds Global Protein Drugs Industry
6. Reportlinker Adds Drug Patent Inventor Report 2010
7. Reportlinker Adds Global Drugstores Industry
8. Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015".
9. Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015
10. Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
11. Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
Breaking Medicine News(10 mins):